Valence Labs Research
Semax
Neurotrophic Research Peptide
- Compound
- Semax
- Category
- Research Peptide
- Available Variant
- 10mg
- Research Status
- Research Use Only
Overview
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from an ACTH fragment and studied as an experimental research peptide.
Preclinical work has examined neurotrophic and molecular signaling, including BDNF/neurotrophin and gene-expression research in experimental models. Those findings should not be treated as established clinical conclusions.
Research Areas
ACTH-Fragment Analogue Research
Semax is studied as a synthetic analogue related to an ACTH fragment in experimental peptide research.
Neurotrophic & Molecular Signaling
Experimental studies have examined neurotrophic and molecular signaling associated with this peptide.
BDNF / Neurotrophin Research
Preclinical research has investigated BDNF and related neurotrophin measurements in laboratory models.
Gene-Expression Research
Experimental work has also examined gene-expression-related questions in model systems.
How It Is Being Studied
Much of the published work involving Semax comes from preclinical and experimental models. Those findings should not be interpreted as established human clinical outcomes.
This page summarizes published research contexts and does not provide treatment, dosing, or administration guidance.
Specifications
Catalog details for this product.
- Product Name
- Semax
- Category
- Research Peptide
- Variant
- 10mg
- Form
- Documentation pending
- Storage
- Documentation pending
- Purity
- Documentation pending
- Intended Use
- Laboratory research use only
Available Documentation
Documentation will appear here as records are published.
Available Product
Semax
10mg